Atherosclerosis, Coronary Clinical Trial
Official title:
The Impact of Particulate Matters Air Pollution on Accelerated Atherosclerosis: A Montelukast Interventional Study for Atherosclerosis Prevention in Modernizing China
Background: Longterm exposure to air pollution has been associated with cardiovascular events and mortality on top of traditional risk factors. Pulmonary inflammation and oxidative stress have been implicated. Brachial (arm) vascular reactivity (flow-mediated dilation FMD) and carotid (neck) artery intima-media thickness (CIMT) are highly reproducible atherosclerosis surrogates, predictive of cardiovascular and stroke outcome. Montelukast is proven safe and effective in alleviating pulmonary inflammation and oxidative stress when used in prevention of asthma episode. Study objectives: 1. To test the hypothesis of pulmonary inflammation and oxidative stress-related vascular dysfunction in PM air pollution. 2. To evaluate the impact of Montelukast treatment as compared with placebo on predictive atherosclerosis surrogates (FMD and IMT). Design: Parallel placebo control, randomized comparative study. Subjects will be randomized to take Montelukast (10mg/daily) or image-matched placebo for 26 weeks. Measures will include PM2.5/PM10, indices of subclinical atherosclerosis (brachial FMD and CIMT), blood inflammatory biomarkers (platelet counts, hsCRP and fibrinogen) and potential confounders (lipids and glucose). Setting: 120 working adults aged 30-60 years in Hong Kong and 80 working adults in Chongqing (CREC Ref No: 2018.157, 2020.398) Main outcome measures: 1. Subclinical atherosclerosis: (a) Endothelial function (brachial FMD) and (b) carotid intima media thickness (CIMT). 2. PM2.5 & PM10 concentrations: real-time measurement by portable devices twice at home and work sites. 3. Blood inflammatory markers-platelet count, hsCRP and Fibrinogen 4. Potential confounders: we shall collect informations on a range of potential confounders, including other air pollutants and traditional risk factors of atherosclerosis, entrusted to be controlled (stable). Expected results: Adults after Montelukast treatment and exposed to high levels of PM2.5 or PM10 would have improved (increased) brachial FMD, and reduction of CIMT as compared with placebo. These will have great implication for comparative vascular epidemiology and development of preventive strategies.
Status | Not yet recruiting |
Enrollment | 200 |
Est. completion date | December 30, 2025 |
Est. primary completion date | December 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 60 Years |
Eligibility | Inclusion Criteria: - asymptomatic Chinese adults - aged 30-60 years with - concordant ambient PM2.5 exposure, both at home and at workplace. Exclusion Criteria: - Those with family history of stroke, cardio-vascular disease - Hypertension with blood pressure >150/90 mmHg - Diabetics Mellitus - Overweight/ obesity (BMI >25kg/M2) - Cigarette smoking or ex-smoker <5 years - Known dyslipidemia defined as fasting LDL-C >4.1mmol/l and triglyceride >3.0 mmol/l. - Physical inactivity, with weekly leisure exercise less than 0.5 hour - Continuous usage of vitamins or herbal medicines in recent one year |
Country | Name | City | State |
---|---|---|---|
Hong Kong | The Chinese University of Hong Kong, Department of Medicine & Therapeutics | Sha Tin |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong | Chongqing Medical University, Hong Kong University of Science and Technology, People's Hospital of Chongqing, University of Sydney |
Hong Kong,
[17] Lin CQ, Li Y, Yuan ZB, Lau AKH, Li, CC, and Fung JCH. Using satellite remote sensing data to estimate the high-resolution distribution of ground-level PM2.5. Remote Sens. Environ 2015;156:117-128.
[18] Lin CQ, Liu G, Lau AKH, Li Y, Li CC, Fung JCH, and Lao XQ. High-resolution satellite remote sensing of provincial PM2.5 trends in China from 2001 to 2015. Atmos. Environ 2018;180:110-116
Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD; American Heart Association Council on Epidemiology and Prevention, Council o — View Citation
Franklin BA, Brook R, Arden Pope C 3rd. Air pollution and cardiovascular disease. Curr Probl Cardiol. 2015 May;40(5):207-38. doi: 10.1016/j.cpcardiol.2015.01.003. Epub 2015 Jan 3. — View Citation
Hajat A, Allison M, Diez-Roux AV, Jenny NS, Jorgensen NW, Szpiro AA, Vedal S, Kaufman JD. Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Ath — View Citation
Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, Thomas D, Peters J, Hodis HN. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005 Feb;113(2):201-6. doi: 10.1289/ehp.7523. — View Citation
Kunzli N, Tager IB. Air pollution: from lung to heart. Swiss Med Wkly. 2005 Dec 10;135(47-48):697-702. doi: 10.4414/smw.2005.11025. — View Citation
Munzel T, Herzog J, Schmidt FP, Sorensen M. Environmental stressors and cardiovascular disease: the evidence is growing. Eur Heart J. 2017 Aug 1;38(29):2297-2299. doi: 10.1093/eurheartj/ehx306. No abstract available. — View Citation
Pope CA 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004 Ja — View Citation
Pun VC, Yu IT, Ho KF, Qiu H, Sun Z, Tian L. Differential effects of source-specific particulate matter on emergency hospitalizations for ischemic heart disease in Hong Kong. Environ Health Perspect. 2014 Apr;122(4):391-6. doi: 10.1289/ehp.1307213. Epub 20 — View Citation
Rajagopalan S, Al-Kindi SG, Brook RD. Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 Oct 23;72(17):2054-2070. doi: 10.1016/j.jacc.2018.07.099. — View Citation
Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991 Sep-Oct;11(5):1245-9. doi: 10.1161/01.atv.11.5.1245. — View Citation
Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS, Woo KS. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese sub — View Citation
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F; Advisory Board of the 3rd Watching the Risk Sympos — View Citation
Woo KS, Chook P, Hu YJ, Lao XQ, Lin CQ, Lee P, Kwok C, Wei AN, Guo DS, Yin YH, Lau K, Leung KS, Leung Y, Celermajer DS. The impact of particulate matter air pollution (PM2.5) on atherosclerosis in modernizing China: a report from the CATHAY study. Int J E — View Citation
Woo KS, Chook P, Raitakari OT, McQuillan B, Feng JZ, Celermajer DS. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2487-93. doi: 10.1161/01.atv.19.10.2487. — View Citation
Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, Lam CW, Metreweli C, Celermajer DS. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation. 2004 Apr 27;109(16):1981-6. doi: 10.1161/01.CIR.0000126599.47470.BE. Epub — View Citation
Woo KS, Robinson JT, Chook P, Adams MR, Yip G, Mai ZJ, Lam CW, Sorensen KE, Deanfield JE, Celermajer DS. Differences in the effect of cigarette smoking on endothelial function in chinese and white adults. Ann Intern Med. 1997 Sep 1;127(5):372-5. doi: 10.7 — View Citation
Yu ITS, hui Zhang Y, San Tam WW, Yan QH, Xu YJ, Xun XJ, Wu W, Ma WJ, Tian LW, Tse LA, Lao XQ. Effect of ambient air pollution on daily mortality rates in Guangzhou, China. Atmos Environ 2012;46:528-535.
* Note: There are 19 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Brachial flow-mediated dilation (FMD) | Changes in endothelial function (brachial FMD) in % | At baseline and 26 weeks of interventional treatment | |
Primary | Carotid intima media thickness (CIMT) | Changes in carotid intima media thickness (CIMT) in mm | At baseline and 26 weeks of interventional treatment | |
Secondary | Changes of platelet count in k/uL | Blood inflammatory markers | At baseline and 26 weeks of interventional treatment | |
Secondary | Changes of hsCRP in mg/ml | Blood inflammatory markers | At baseline and 26 weeks of interventional treatment | |
Secondary | Changes of Fibrinogen in g/l | Blood inflammatory markers | At baseline and 26 weeks of interventional treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03427996 -
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
|
||
Not yet recruiting |
NCT03174418 -
Fluid-dynamics in Bifurcation PCI
|
N/A | |
Not yet recruiting |
NCT03813017 -
Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05600088 -
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina
|
N/A | |
Completed |
NCT03011775 -
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
|
Phase 4 | |
Completed |
NCT00115583 -
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
|
N/A | |
Completed |
NCT03149042 -
Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.
|
||
Not yet recruiting |
NCT05540223 -
Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System
|
N/A | |
Completed |
NCT02389946 -
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
|
N/A | |
Completed |
NCT01234870 -
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
|
Phase 2/Phase 3 | |
Completed |
NCT03471611 -
Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis
|
Phase 1 | |
Completed |
NCT00353795 -
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
|
N/A | |
Enrolling by invitation |
NCT04810364 -
HIV Infection And Evolvement of Atherosclerotic Plaque
|
||
Active, not recruiting |
NCT04175626 -
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
|
||
Recruiting |
NCT00146887 -
Comparison of Coronary CT Angiography to Invasive Coronary Angiography
|
N/A | |
Completed |
NCT05492084 -
Personalized Risk of Rapidly Progressive Atherosclerosis
|
||
Recruiting |
NCT04853511 -
Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability
|
||
Completed |
NCT03815032 -
Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison
|
N/A | |
Active, not recruiting |
NCT03129503 -
Optical Coherence Tomography in Acute Coronary Syndrome
|
||
Recruiting |
NCT06393894 -
Latvian Early Atherosclerosis Registry
|